Mengting Ding
Shenzhen, 518000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Retraction notice to "High expression of enhancer RNA MARC1 or its activation by DHT is associated with the malignant behavior in bladder cancer" [Exp. Cell Res. Volume 370, Issue 2, 15 September 2018, Pages 303-311].
Journal: Experimental cell research
Published: August 31, 2024
Impact of Poly(Ester Amide) Structure on Properties and Drug Delivery for Prostate Cancer Therapy.
Journal: BME frontiers
Published: May 13, 2023
Prepubertal-type teratoma in a postpubertal patient: case report and review of literature.
Journal: International journal of clinical and experimental pathology
Published: June 03, 2020
Lentivirus-mediated shRNA targeting MUTYH inhibits malignant phenotypes of bladder cancer SW780 cells.
Journal: OncoTargets and therapy
Published: October 03, 2018
Enhancer RNA - P2RY2e induced by estrogen promotes malignant behaviors of bladder cancer.
Journal: International journal of biological sciences
Published: May 08, 2018
High expression of enhancer RNA MARC1 or its activation by DHT is associated with the malignant behavior in bladder cancer.
Journal: Experimental cell research
Published: April 24, 2018
Oestrogen promotes tumorigenesis of bladder cancer by inducing the enhancer RNA-eGREB1.
Journal: Journal of cellular and molecular medicine
Published: April 02, 2018
Enhancer RNAs (eRNAs): New Insights into Gene Transcription and Disease Treatment.
Journal: Journal of Cancer
Published: March 01, 2018
Current Advances on the Important Roles of Enhancer RNAs in Gene Regulation and Cancer.
Journal: BioMed research international
Published: January 04, 2018
Synthetic artificial "long non-coding RNAs" targeting oncogenic microRNAs and transcriptional factors inhibit malignant phenotypes of bladder cancer cells.
Journal: Cancer letters
Published: December 20, 2017
Showing 1-12 of 12
Last Updated: 09/26/2026